134 related articles for article (PubMed ID: 8791980)
1. The entero-insular axis in polycystic ovarian syndrome.
Gama R; Norris F; Wright J; Morgan L; Hampton S; Watkins S; Marks V
Ann Clin Biochem; 1996 May; 33 ( Pt 3)():190-5. PubMed ID: 8791980
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.
Conway GS; Clark PM; Wong D
Clin Endocrinol (Oxf); 1993 Feb; 38(2):219-22. PubMed ID: 8435903
[TBL] [Abstract][Full Text] [Related]
3. Incretin levels in polycystic ovary syndrome.
Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
[TBL] [Abstract][Full Text] [Related]
4. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
Nauck MA; Siemsglüss J; Orskov C; Holst JJ
Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Clin Sci (Lond); 1999 Apr; 96(4):335-42. PubMed ID: 10087239
[TBL] [Abstract][Full Text] [Related]
6. Elevated post-prandial gastric inhibitory polypeptide concentrations in hypertriglyceridaemic subjects.
Gama R; Norris F; Morgan L; Hampton S; Wright J; Marks V
Clin Sci (Lond); 1997 Oct; 93(4):343-7. PubMed ID: 9404226
[TBL] [Abstract][Full Text] [Related]
7. Hyperinsulinaemia of hypertriglyceridaemia: a reappraisal.
Gama R; Shah S; Wright J; Marks V
Diabet Med; 1995 Apr; 12(4):321-4. PubMed ID: 7600747
[TBL] [Abstract][Full Text] [Related]
8. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).
Ranganath L; Schaper F; Gama R; Morgan L; Wright J; Teale D; Marks V
Diabetes Metab Res Rev; 1999; 15(6):390-4. PubMed ID: 10634963
[TBL] [Abstract][Full Text] [Related]
10. Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction?
Maliqueo M; Atwater I; Lahsen R; Pérez-Bravo F; Angel B; Sir-Petermann T
Hum Reprod; 2003 Dec; 18(12):2683-8. PubMed ID: 14645192
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Niederau C; Berger M; Stremmel W; Starke A; Strohmeyer G; Ebert R; Siegel E; Creutzfeldt W
Diabetologia; 1984 Jun; 26(6):441-4. PubMed ID: 6381191
[TBL] [Abstract][Full Text] [Related]
12. The ageing entero-insular axis.
Ranganath L; Sedgwick I; Morgan L; Wright J; Marks V
Diabetologia; 1998 Nov; 41(11):1309-13. PubMed ID: 9833938
[TBL] [Abstract][Full Text] [Related]
13. Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome.
Aydin K; Arusoglu G; Koksal G; Cinar N; Aksoy DY; Yildiz BO
Clin Endocrinol (Oxf); 2014 Oct; 81(4):588-92. PubMed ID: 24730585
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
Kruszynska YT; Ghatei MA; Bloom SR; McIntyre N
Hepatology; 1995 Apr; 21(4):933-41. PubMed ID: 7705803
[TBL] [Abstract][Full Text] [Related]
15. Entero-insular axis in children with anorexia nervosa.
Tomasik PJ; Sztefko K; Starzyk J; Rogatko I; Szafran Z
Psychoneuroendocrinology; 2005 May; 30(4):364-72. PubMed ID: 15694116
[TBL] [Abstract][Full Text] [Related]
16. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
[TBL] [Abstract][Full Text] [Related]
17. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
18. The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study.
Pontikis C; Yavropoulou MP; Toulis KA; Kotsa K; Kazakos K; Papazisi A; Gotzamani-Psarakou A; Yovos JG
J Womens Health (Larchmt); 2011 Jun; 20(6):971-6. PubMed ID: 21671782
[TBL] [Abstract][Full Text] [Related]
19. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
20. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
